CanSino Biologics, Inc. Class H (HK:6185)
:6185
Comparison Results
Guangzhou Baiyunshan Pharmaceutical Holdings Company
HK$18.75
HK$40.67B
8.90
1.56%
―
Livzon Pharmaceutical Group
HK$30.94
HK$31.87B
11.61
9.46%
0 Buy
0 Hold
1 Sell
Moderate Sell
Shanghai Fosun Pharmaceutical (Group) Co
HK$19.63
HK$75.27B
14.15
41.21%
2 Buy
0 Hold
0 Sell
Moderate Buy
China Resources Pharmaceutical Group Ltd.
HK$4.61
HK$39.83B
6.37
26.68%
5 Buy
0 Hold
0 Sell
Strong Buy
Hansoh Pharmaceutical Group Company Limited
HK$38.46
HK$234.70B
35.71
70.18%
7 Buy
0 Hold
0 Sell
Strong Buy
Performance Comparison
HK:6185
CanSino Biologics, Inc. Class H
33.02
2.77
9.16%
HK:0874
Guangzhou Baiyunshan Pharmaceutical Holdings Company
16.88
0.89
5.60%
HK:1513
Livzon Pharmaceutical Group
28.24
3.00
11.89%
HK:2196
Shanghai Fosun Pharmaceutical (Group) Co
19.60
5.77
41.73%
HK:3320
China Resources Pharmaceutical Group Ltd.
6.22
1.34
27.33%
HK:3692
Hansoh Pharmaceutical Group Company Limited
38.46
15.91
70.55%